Cicatrix Cream in Cutaneous Groves
NCT01018212 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2010-12-08
Summary
The purpose of the study is to assess the effect of CICATRIX (Asian Gotu Kola or Pennywort) usage in the treatment of cutaneous grooves. The duration of this phase 2 clinical trial will be 4 months.
Conditions
- Cutaneous Groves
Interventions
- OTHER
-
Cicatrix cream
We will be carried out the topical application of the product (Cicatrix cream) in the lesions auto administration three times a day during four months, being controlled by the specialist in months consultations. The dose of 0,1 ml of cream for each cm. of surface, To the patient will be explained the technique of the application.
Sponsors & Collaborators
-
Catalysis SL
lead INDUSTRY
Principal Investigators
-
Fernanda Pastrana, MD · Pediatric Hospital Juan Manuel Marquez
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 10 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-09-30
- Primary Completion
- 2010-12-31
- Completion
- 2010-12-31
Countries
- Cuba
Study Locations
More Related Trials
-
Actinic Keratosis Study
NCT02019355 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands
NCT00115154 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Phase II Study of SR-T100 to Treat Actinic Keratosis
NCT01516515 ·Status: COMPLETED ·Phase: PHASE2
-
A Study To Evaluate The Contact Sensitization Potential Of Tazarotene Foam On Skin In Healthy Volunteers
NCT01114841 ·Status: COMPLETED ·Phase: PHASE1
-
Cellular and Molecular Events During Treatment of Actinic Keratosis With Imiquimod 5% Cream
NCT00335179 ·Status: COMPLETED ·Phase: PHASE2
-
Cryotherapy in Combination with Red Light PDT for Actinic Keratosis of Full Face
NCT06745999 ·Status: RECRUITING ·Phase: PHASE4
-
Study on the Efficacy of LAS41005 in the Treatment of Actinic Keratosis
NCT00987246 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis
NCT02029066 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of Madecassoside and 5 % Panthenol Cream in Post Photodynamic Therapy for Actinic Keratosis
NCT05937529 ·Status: COMPLETED ·Phase: NA
-
Photodynamic Therapy of Actinic Keratoses With Alacare®
NCT01571336 ·Status: COMPLETED
-
Fractional Carbon Dioxide Laser: A Novel Therapeutic Option for Lichen Simplex Chronicus
NCT06267066 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis
NCT00116649 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Salkera Emollient Foam in the Treatment of Moderate to Severe Keratosis Pilaris, a Prospective Study
NCT00944216 ·Status: TERMINATED ·Phase: PHASE4
-
Effectivity and Safety of Combination Cream of Salicylic Acid, Aqua Posae Filiformis, Niacinamide, Lipohydroxy Acid, Procerad and Zinc PCA
NCT05497323 ·Status: UNKNOWN ·Phase: PHASE1
-
Striae Distensae Treatment Using Deep Skin Abrasion
NCT07087405 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effectiveness and Safety of Zingiber Officinale Transdermal Patch for Acne Vulgaris; Study of Interleukin 1 and Skin Microbiome
NCT06787222 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
NCT02654769 ·Status: COMPLETED ·Phase: PHASE3
-
LAS41005 in Hyperkeratotic Actinic Keratosis
NCT01358851 ·Status: COMPLETED ·Phase: PHASE2
-
Double-blind, Randomized, Vehicle- and Comparator-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of LAS41007 in the Treatment of Actinic Keratosis
NCT01265602 ·Status: COMPLETED ·Phase: PHASE3
-
A Pre-market Study to Evaluate the Performance and Safety of a Skin Preparation Device for Removal of Dry Crusty Skin
NCT05356572 ·Status: COMPLETED ·Phase: NA
-
The Effectiveness and Safety of Cleanser Containing Triethyl Citrate, Pyruvic Acid, Combination Cream Containing Triethyl Citrate, Ethyl Linoleate, GT Peptide-10, Salicylic Acid 0,5%, Zinc Lactate, Hyaluronic Acid and Spot Cream Containing Triethyl Citrate, Ethyl Linoleate, GT Peptide-10, Honokiol
NCT06775314 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of Cryotherapy Versus 5-Fluorouracil in the Treatment of Actinic Keratosis
NCT06461442 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Multiple-dose Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis
NCT02559934 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel
NCT00239135 ·Status: COMPLETED ·Phase: PHASE2
-
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
NCT01541553 ·Status: COMPLETED ·Phase: PHASE3